18263819. Device and Method for Separating Blood Plasma from Whole Blood simplified abstract (Robert Bosch GmbH)
Contents
- 1 Device and Method for Separating Blood Plasma from Whole Blood
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 Device and Method for Separating Blood Plasma from Whole Blood - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Original Abstract Submitted
Device and Method for Separating Blood Plasma from Whole Blood
Organization Name
Inventor(s)
Hannah Bott of Straubenhardt (DE)
Device and Method for Separating Blood Plasma from Whole Blood - A simplified explanation of the abstract
This abstract first appeared for US patent application 18263819 titled 'Device and Method for Separating Blood Plasma from Whole Blood
Simplified Explanation
The abstract describes a microfluidic device that separates blood plasma from whole blood by introducing whole blood into a separation chamber, sedimenting blood cells, and sublayering the blood plasma using a transport medium with higher density.
- The microfluidic device has at least one separation chamber with an inlet and an outlet.
- The inlet of the separation chamber is at a lower height than the outlet.
- Whole blood is introduced into the separation chamber.
- Blood cells are sedimented from the whole blood.
- Blood plasma is separated and sublayered using a transport medium with higher density.
Potential Applications
This technology could be applied in medical diagnostics, blood testing, and research laboratories for efficient separation of blood components.
Problems Solved
This technology solves the problem of separating blood plasma from whole blood in a quick and efficient manner, which is crucial for various medical and research applications.
Benefits
The benefits of this technology include faster and more accurate separation of blood components, reduced sample processing time, and improved efficiency in blood testing procedures.
Potential Commercial Applications
The potential commercial applications of this technology include medical device manufacturing, biotechnology companies, and research institutions looking to streamline blood separation processes.
Possible Prior Art
One possible prior art for this technology could be existing methods of blood separation using centrifugation techniques in traditional laboratory settings.
Unanswered Questions
How does this technology compare to traditional centrifugation methods for blood separation?
This technology offers a more compact and potentially automated solution for blood separation compared to traditional centrifugation methods. It would be interesting to see a direct comparison of efficiency, speed, and cost between the two methods.
What are the scalability and cost implications of implementing this technology in different settings?
Understanding how scalable and cost-effective this technology is for different applications and settings would be crucial for its widespread adoption. Further research and development could provide insights into these aspects.
Original Abstract Submitted
A microfluidic device includes at least one separation chamber having an inlet and an outlet. The inlet opens into the separation chamber at a lower height than the outlet. In order to separate blood plasma from whole blood, whole blood is introduced into the separation chamber of the microfluidic device, blood cells are sedimented from the whole blood, and blood plasma separated in the process is sublayered using a transport medium which has a higher density than the blood plasma.
